39 related articles for article (PubMed ID: 29571661)
1. Whole-Exome Sequencing Identifies Two Discrete Druggable Signaling Pathways in Follicular Thyroid Cancer.
Erinjeri NJ; Nicolson NG; Deyholos C; Korah R; Carling T
J Am Coll Surg; 2018 Jun; 226(6):950-959.e5. PubMed ID: 29571661
[TBL] [Abstract][Full Text] [Related]
2. REPURPOSING GERMLINE EXOMES OF THE CANCER GENOME ATLAS DEMANDS A CAUTIOUS APPROACH AND SAMPLE-SPECIFIC VARIANT FILTERING.
Koire A; Katsonis P; Lichtarge O
Pac Symp Biocomput; 2016; 21():207-18. PubMed ID: 26776187
[TBL] [Abstract][Full Text] [Related]
3. Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.
Pozdeyev N; Gay LM; Sokol ES; Hartmaier R; Deaver KE; Davis S; French JD; Borre PV; LaBarbera DV; Tan AC; Schweppe RE; Fishbein L; Ross JS; Haugen BR; Bowles DW
Clin Cancer Res; 2018 Jul; 24(13):3059-3068. PubMed ID: 29615459
[No Abstract] [Full Text] [Related]
4. BRAF
Kim HK; Lee I; Lee J; Chang HS; Soh EY; Park IS; Kim JH; Rho YS; Lee DJ
Head Neck; 2018 Aug; 40(8):1707-1718. PubMed ID: 29573027
[TBL] [Abstract][Full Text] [Related]
5. Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy.
Veeramachaneni R; Walker T; Revil T; Weck A; Badescu D; O'Sullivan J; Higgins C; Elliott L; Liloglou T; Risk JM; Shaw R; Hampson L; Hampson I; Dearden S; Woodwards R; Prime S; Hunter K; Parkinson EK; Ragoussis J; Thakker N
Sci Rep; 2019 Aug; 9(1):11992. PubMed ID: 31427592
[TBL] [Abstract][Full Text] [Related]
6. Whole Exome Sequencing of Multiple Atypical Meningiomas in a Patient without History of Neurofibromatosis Type II: A Case Report.
Lyu J; Quan Y; Wang JB; Gong SP
Am J Case Rep; 2020 May; 21():e923928. PubMed ID: 32461543
[TBL] [Abstract][Full Text] [Related]
7. Molecular typing and prognostic risk models for ovarian cancer: a study based on cell differentiation trajectory.
Chen T; Ni T; Mu L; Ying Z; Zhang H; Wang Z
Front Cell Dev Biol; 2023; 11():1131494. PubMed ID: 37719881
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF.
Mukherjee B; Tiwari A; Palo A; Pattnaik N; Samantara S; Dixit M
Cell Death Discov; 2022 Nov; 8(1):442. PubMed ID: 36329016
[TBL] [Abstract][Full Text] [Related]
9. The genomic landscape of canine osteosarcoma cell lines reveals conserved structural complexity and pathway alterations.
Megquier K; Turner-Maier J; Morrill K; Li X; Johnson J; Karlsson EK; London CA; Gardner HL
PLoS One; 2022; 17(9):e0274383. PubMed ID: 36099278
[TBL] [Abstract][Full Text] [Related]
10. Thyroid and Breast Cancer in 2 Sisters With Monoallelic Mutations in the Ataxia Telangiectasia Mutated (
Miasaki FY; Saito KC; Yamamoto GL; Boguszewski CL; de Carvalho GA; Kimura ET; Kopp PA
J Endocr Soc; 2022 Apr; 6(4):bvac026. PubMed ID: 35284771
[TBL] [Abstract][Full Text] [Related]
11. Integration of gene co-expression analysis and multi-class SVM specifies the functional players involved in determining the fate of HTLV-1 infection toward the development of cancer (ATLL) or neurological disorder (HAM/TSP).
Zarei Ghobadi M; Emamzadeh R
PLoS One; 2022; 17(1):e0262739. PubMed ID: 35041720
[TBL] [Abstract][Full Text] [Related]
12. Predictive Biomarkers of Dicycloplatin Resistance or Susceptibility in Prostate Cancer.
Liu M; Zhou X; Liu J; Lu C; Zhang G; Zhang J; Jiao S
Front Genet; 2021; 12():669605. PubMed ID: 34386035
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the genomic landscape of yolk sac tumors reveals mechanisms of evolution and chemoresistance.
Zong X; Zhang Y; Peng X; Cao D; Yu M; Wang J; Li H; Guo X; Liang H; Yang J
Nat Commun; 2021 Jun; 12(1):3579. PubMed ID: 34117242
[TBL] [Abstract][Full Text] [Related]
14. The importance of CDC27 in cancer: molecular pathology and clinical aspects.
Kazemi-Sefat GE; Keramatipour M; Talebi S; Kavousi K; Sajed R; Kazemi-Sefat NA; Mousavizadeh K
Cancer Cell Int; 2021 Mar; 21(1):160. PubMed ID: 33750395
[TBL] [Abstract][Full Text] [Related]
15. PRSS1 Upregulation Predicts Platinum Resistance in Ovarian Cancer Patients.
Xing L; Tian S; Mi W; Zhang Y; Zhang Y; Zhang Y; Xu F; Zhang C; Lou G
Front Cell Dev Biol; 2020; 8():618341. PubMed ID: 33585454
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of Tumor-Infiltrating Immune Cells and Relevant Therapeutic Strategy in Esophageal Cancer.
Lu G; Chen L; Wu S; Feng Y; Lin T
Dis Markers; 2020; 2020():8974793. PubMed ID: 32454908
[TBL] [Abstract][Full Text] [Related]
17. New Insights Into the Complex Mutational Landscape of Sézary Syndrome.
Mirza AS; Horna P; Teer JK; Song J; Akabari R; Hussaini M; Sokol L
Front Oncol; 2020; 10():514. PubMed ID: 32373524
[TBL] [Abstract][Full Text] [Related]
18. Integrated assessment of CDK1 upregulation in thyroid cancer.
Zheng HP; Huang ZG; He RQ; Lu HP; Dang YW; Lin P; Wen DY; Qin YY; Luo B; Li XJ; Mo WJ; Yang H; He Y; Chen G
Am J Transl Res; 2019; 11(12):7233-7254. PubMed ID: 31934275
[TBL] [Abstract][Full Text] [Related]
19. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
[TBL] [Abstract][Full Text] [Related]
20. Genomic aberrations in cell cycle genes predict progression of
Heinrich MC; Patterson J; Beadling C; Wang Y; Debiec-Rychter M; Dewaele B; Corless CL; Duensing A; Raut CP; Rubin B; Ordog T; van de Rijn M; Call J; Mühlenberg T; Fletcher JA; Bauer S
Clin Sarcoma Res; 2019; 9():3. PubMed ID: 30867899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
